Completed
A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis
NCT02340234
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Dermatology Research Associate Los Angeles, California, United States
- UCSD Division of Dermatology San Diego, California, United States
- Univ of Calif-San Francisco San Francisco, California, United States
- University of Colorado; Anschutz Cancer Pavilion Aurora, Colorado, United States